QQ客服 官方微博 反馈留言

	Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells
	You, Fengtao; Jiang, Licui; Zhang, Bozhen; Lu, Qiang; Zhou, Qiao; Liao, Xiaoyang; Wu, Hong; Du, Kaiqi; Zhu, Youcai; Meng, Huimin
刊名	SCIENCE CHINA-LIFE SCIENCES
	2016
卷号	59期号:[db:dc_citation_issue]页码:386-397
关键词	MUC1 solid tumor seminal vesicle cancer CAR-T therapy
ISSN号	1674-7305
DOI	[db:dc_identifier_doi]
URL标识	查看原文
WOS记录号	[DB:DC_IDENTIFIER_WOSID]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3221494
专题	西安交通大学
推荐引用方式 GB/T 7714	You, Fengtao,Jiang, Licui,Zhang, Bozhen,et al. Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells[J]. SCIENCE CHINA-LIFE SCIENCES,2016,59([db:dc_citation_issue]):386-397.
APA	You, Fengtao.,Jiang, Licui.,Zhang, Bozhen.,Lu, Qiang.,Zhou, Qiao.,...&Yang, Lin.(2016).Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells.SCIENCE CHINA-LIFE SCIENCES,59([db:dc_citation_issue]),386-397.
MLA	You, Fengtao,et al."Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells".SCIENCE CHINA-LIFE SCIENCES 59.[db:dc_citation_issue](2016):386-397.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。